Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial-Reference-Cited by-同舟云学术

Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial

Published:2019-09-11 Issue:12 Volume:35 Page:2097-2102
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Bilezikian John P.¹,Hattersley Gary²,Mitlak Bruce H.²,Hu Ming-Yi²,Fitzpatrick Lorraine A.²,Dabrowski Christine²,Miller Paul D.³,Papapoulos Socrates E.⁴

Affiliation:

1. College of Physicians and Surgeons, Columbia University, New York, NY, USA;

2. Research & Development, Radius Health, Inc, Waltham, MA, USA;

3. Colorado Center for Bone Research at Panorama Orthopedics and Spine Center, Golden, CO, USA;

4. Center for Bone Quality, Leiden University Medical Center, Leiden, The Netherlands

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1656955

Reference18 articles.

1. Epidemiology and outcomes of osteoporotic fractures

2. The Aging Kidney: Physiological Changes

3. Relationship between age, renal function and bone mineral density in the US population

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abaloparatid – eine neue osteoanabole Therapieoption für die Osteoporose bei postmenopausalen Frauen;Osteologie;2024-07-10

2. Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when?;European Journal of Endocrinology;2024-06-28

3. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials;BMJ;2023-05-02

4. Is abaloparatide more efficacious on increasing bone mineral density than teriparatide for women with postmenopausal osteoporosis? An updated meta-analysis;Journal of Orthopaedic Surgery and Research;2023-02-17

5. Parathyroid Hormone and Parathyroid Hormone Analogs: Clinical Applications and Perspectives in Osteoporosis Treatment;Pharmacological Interventions for Osteoporosis;2023